References
Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375 (9718): 895–905.
Parati G, Ochoa JE, Lombardi C, Bilo G . Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013; 10: 143–155.
Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S . The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57: 160–166.
Nagai M, Hoshide S, Nishikawa M, Masahisa S, Kario K . Visit-to-visit blood pressure variability in the elderly: associations with cognitive impairment and carotid artery remodeling. Atherosclerosis 2014; 233: 19–26.
Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007; 49: 1265–1270.
Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K . Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38: 852–857.
Pierdomenico SD, Di Nicola M, Esposito AL, Di Mascio R, Ballone E, Lapenna D et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 2009; 22: 842–847.
Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005; 45: 505–512.
Zakopoulos NA, Tsivgoulis G, Barlas G, Spengos K, Manios E, Ikonomidis I et al. Impact of the time rate of blood pressure variation on left ventricular mass. J Hypertens 2006; 24: 2071–2077.
Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36: 901–906.
Kangawa K, Matsuo H . Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Biophys Res Commun 1984; 118: 131–139.
Sudoh T, Kangawa K, Minamino N, Matsuo H . A new natriuretic peptide in porcine brain. Nature 1988; 332 (6159): 78–81.
Minamino N, Nishikimi T . Natriuretic peptides. In: Kastin AJ . (ed). Handbook of Biologically Active Peptides. Academic Press: San Diego, CA, USA, 2013, pp 1415–1422.
Kato J . Natriuretic peptides. In: Caplan M . (ed). Reference Module in Biomedical Sciences. Elsevier: London, UK, 2014.
Kato J, Kitamura K, Matsui E, Tanaka M, Ishizaka Y, Kita T et al. Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension. Hypertens Res 1999; 22: 61–65.
Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T et al. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996; 81: 180–183.
CAS PubMed Google Scholar
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982–992.
Kawano S, Kawagoe Y, Kuwasako K, Shimamoto S, Igarashi K, Tokashiki M et al. Gender-related alterations in plasma adrenomedullin level and its correlation with body weight gain. Endocr Connect 2015; 4: 43–49.
Satoh M, Hosaka M, Asayama K, Kikuya M, Inoue R, Metoki H et al. Association between N-terminal pro B-type natriuretic peptide and day-to-day blood pressure and heart rate variability in a general population: the Ohasama study. J Hypertens 2015; 33: 1536–1541.
Ogawa N, Komura H, Kuwasako K, Kitamura K, Kato J . Plasma levels of natriuretic peptides and development of chronic kidney disease. BMC Nephrol 2015; 16: 171.
Yano Y, Fujimoto S, Kramer H, Sato Y, Konta T, Iseki K et al. Long-term blood pressure variability, new-onset diabetes mellitus, and new-onset chronic kidney disease in the Japanese general population. Hypertension 2015; 66: 30–36.
Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K et al. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 2002; 25: 887–892.
Giannessi D, Andreassi MG, Del Ry S, Clerico A, Colombo MG, Dini N . Possibility of age regulation of the natriuretic peptide C-receptor in human platelets. J Endocrinol Invest 2001; 24: 8–16.
Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Hayashi M . Ambulatory blood pressure variability and brachial-ankle pulse wave velocity in untreated hypertensive patients. J Hum Hypertens 2006; 20: 529–536.
Bahrainwala J, Patel A, Diaz KM, Veerabhadrappa P, Cohen DL, Cucchiara A et al. Ambulatory Arterial Stiffness Index and circadian blood pressure variability. J Am Soc Hypertens 2015; 9: 705–710.
Stabouli S, Papakatsika S, Kotronis G, Papadopoulou-Legbelou K, Rizos Z, Kotsis V . Arterial stiffness and SBP variability in children and adolescents. J Hypertens 2015; 33: 88–95.
Song H, Wei F, Liu Z, Zhao Y, Ye L, Lu F et al. Visit-to-visit variability in systolic blood pressure: correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients. Clin Exp Hypertens 2015; 37: 63–69.
Yambe M, Tomiyama H, Koji Y, Motobe K, Shiina K, Gulnisia Z et al. B-type natriuretic peptide and arterial stiffness in healthy Japanese men. Am J Hypertens 2006; 19: 443–447.
Shroff GR, Cen YY, Duprez DA, Bart BA . Relationship between carotid artery stiffness index, BNP and high-sensitivity CRP. J Hum Hypertens 2009; 23: 783–787.
Rutten JH, Mattace-Raso FU, Verwoert GC, Lindemans J, Hofman A, Witteman JC et al. Arterial stiffness as determinant of increased amino terminal pro-B-type natriuretic peptide levels in individuals with and without cardiovascular disease - the Rotterdam Study. J Hypertens 2010; 28: 2061–2067.
Liu Z, Peng J, Lu F, Zhao Y, Wang S, Sun S et al. Salt loading and potassium supplementation: effects on ambulatory arterial stiffness index and endothelin-1 levels in normotensive and mild hypertensive patients. J Clin Hypertens 2013; 15: 485–496.
Hummel SL, Seymour EM, Brook RD, Kolias TJ, Sheth SS, Rosenblum HR et al. Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction. Hypertension 2012; 60: 1200–1206.
Jablonski KL, Fedorova OV, Racine ML, Geolfos CJ, Gates PE, Chonchol M et al. Dietary sodium restriction and association with urinary marinobufagenin, blood pressure, and aortic stiffness. Clin J Am Soc Nephrol 2013; 8: 1952–1959.
Mitchell GF, Izzo JL Jr, Lacourcière Y, Ouellet JP, Neutel J, Qian C et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002; 105: 2955–2961.
Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995; 98: 257–265.